Identifying risk factors and disease severity in leptospirosis: A meta-analysis of clinical predictors
Pavlo Petakh(Kyiv School of Economics), Oleksandr Kamyshnyi(I.Horbachevsky Ternopil National Medical University), Vitaliia Isevych(Uzhhorod National University), Larysa Rostoka(Uzhhorod National University)
Cited by 18
Related Papers
Effects of metformin on the gut microbiota: A systematic review
|Molecular Metabolism|2023|91
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
|Biomedicine & Pharmacotherapy|2023|70
Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection
|Antioxidants|2024|64
Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions
|Biomedicines|2024|51
Current treatment options for leptospirosis: a mini-review
|Frontiers in Microbiology|2024|48